Found 12 matching trials
Personalized Neoantigen Peptide Vaccines for Solid Tumors PHASE1 This clinical trial is studying the safety and efficacy of a personalized c...
Show More Location
Horizon Cancer Excellence Center, Bumrungrad International Hospital
Learn More & Join Trial
Safety and Immunogenicity of a Personalized Synthetic Long Peptide Breast Cancer Vaccine Strategy in Patients With Persistent Triple-Negative Breast Cancer Following Neoadjuvant Chemotherapy PHASE1 The most important consideration in the design of this clinical trial is to...
Show More Location
Multiple Locations
Learn More & Join Trial
A Phase 1b/2, Multi-center, Single Arm Study to Assess the Safety and Efficacy of Neoantigen Synthetic Long Peptide Vaccines in Patients With Local Or Metastatic Solid Tumors PHASE1 A Phase 1b/2, Multi-center, Single Arm Study to Assess the Safety and Effic...
Show More Status
Enrolling By Invitation
Location
Precision NextGen Oncology & Research Center
Learn More & Join Trial
Neoantigen-based Personalized Vaccine Combined With Immune Checkpoint Blockade Therapy in Patients With Newly Diagnosed, Unmethylated Glioblastoma PHASE1 This is a single institution, open-label, multi-arm, pilot study assessing ...
Show More Location
Washington University School of Medicine
Learn More & Join Trial
Atezolizumab Given in Combination With a Personalized Vaccine in Patients With Urothelial Cancer PHASE1 The purpose of this study is to determine the good and bad effects of atezo...
Show More Location
Icahn School of Medicine at Mount Sinai
Learn More & Join Trial
Personalized Cancer Vaccine (PCV) Strategy in Patients With Solid Tumors and Molecular Residual Disease PHASE1 This is a phase 1 clinical trial to evaluate the safety, feasibility and im...
Show More Learn More & Join Trial
Expanded Access To Neoantigen Synthetic Long Peptide Vaccines in Patients With Local Or Metastatic Solid Tumors N/A This is an intermediate patient expanded access protocol for treatment of p...
Show More Learn More & Join Trial
Neoepitope-based Personalized Vaccine Approach in Pediatric Patients With Recurrent Brain Tumors PHASE1 The early clinical development paradigm for chemotherapeutic agents has sig...
Show More Location
Multiple Locations
Learn More & Join Trial
Safety and Immunogenicity of Personalized Genomic Vaccine and Tumor Treating Fields (TTFields) to Treat Glioblastoma PHASE1 The purpose of this study is to use precision medicine in the form of a vac...
Show More Status
Active Not Recruiting
Location
Albert Einstein College of Medicine
Learn More & Join Trial
Neoantigen Peptide Vaccine Plus Pembrolizumab in Renal Cell Carcinoma PHASE1 This is a Phase I, single-center, open-label, single-arm clinical trial to ...
Show More Location
Peking University First Hospital
Learn More & Join Trial